This is investment research, not personal financial advice.

PEXA Group (ASX:PXA) closed at A$7.31 on Monday, up 9.43%, the biggest gain in the S&P/ASX 200 on the day (Fool 2026). That bounce needs its context: two trading days earlier, on Friday 28 August, the same shares fell 17.43% to A$6.68 on 4.84 million shares, roughly fourteen times their usual turnover, after the company released its FY26 results before the open (StockAnalysis 2026). Thursday's close was A$8.09. Two sessions, one results release, and a net fall of 9.6% that still leaves the stock 57% below its 52-week high close of A$16.92.

The two sessions are arguing with each other. Friday's sellers treated the FY27 guidance as a break in the earnings story. Monday's buyers treated Friday as an over-reaction to numbers that were, in part, already signalled. Both are looking past the same fact: the largest single number in PEXA's equity story is no longer in management's hands. On 30 September 2026, IPART, the NSW pricing tribunal, hands its final report on electronic lodgement fees to the NSW Government. Its July draft proposed cutting PEXA's regulated revenue by about 20% from FY28, which PEXA sizes at roughly A$70 million of annual revenue (PEXA 2026e; IPART 2026). That is worth more than the FY27 guidance cut the market spent Friday pricing.

Friday's 17 per cent was about guidance, not the FY26 print

The FY26 result itself was the strongest since listing. Revenue from continuing operations rose 7% to A$406.9 million, group EBITDA rose 12% to A$151.7 million with margin up 1.7 percentage points to 37.3%, and net profit after tax and amortisation rose 35% to A$65.3 million. Free cash flow was A$93.5 million, up 39%, and net debt fell to A$158.7 million, or 1.0x EBITDA, from 1.8x a year earlier (PEXA 2026a). Statutory net profit from continuing operations swung from a A$65.6 million loss to a A$19.2 million profit. On the guidance-basis core measure, NPAT was A$26.3 million, at the top end of the range management had promised in May (PEXA 2026c).

The guidance was the problem. For FY27 PEXA directed the market to revenue of A$385-415 million, a group EBITDA margin of 31.5-33.5%, and NPAT of A$5-20 million (PEXA 2026a). Read against FY26's 37.3% margin and A$26.3 million NPAT, the midpoints imply margin down about four points and profit roughly halved. International operating cash flow is guided to another A$55-65 million outflow.

The driver is volume, and management quantified it. The results presentation includes a sensitivity table: absent further cost cuts, Australian transfer volumes down 5% imply a FY27 group EBITDA margin of 34.5-36.0%; down 10%, 33.0-34.5%; down 15%, 31.0-32.5%; down 20%, 29.0-30.5% (PEXA 2026g). The guidance band of 31.5-33.5% sits between the minus-10% and minus-15% rows. Management is telling the market it expects Australian transfers to fall somewhere around 12-15% in FY27. The macro backdrop is the RBA cash rate, unchanged at 4.35% through the June and August 2026 decisions, plus what the company calls "recent changes to the taxation of property" (RBA 2026; PEXA 2026a).

The softening has already started in the disclosed data. PEXA's 18 August announcement, lodged with its IPART submission, noted July 2026 transfer volumes of about 192,000 (PEXA 2026d). FY26 transfers were 2.673 million, an average of about 223,000 a month (computed from PEXA 2026d and 2026g). July ran roughly 14% below that run rate. In other words, a careful reader of the 18 August update already knew FY27 volumes were breaking lower before Friday's open. That is the strongest single piece of evidence that Friday's fall overshot: the guidance reset was substantially pre-signalled ten days earlier.

There is a second-half fade visible in the FY26 numbers too. First-half revenue was A$215.3 million, up 10%, with A$15.4 million of continuing-operations NPAT; the second half therefore delivered roughly A$191.6 million of revenue and A$3.8 million of NPAT (PEXA 2026h, computed). The trend management guided for FY27 was already in the FY26 exit rate.

The regulator's A$70 million sentence

The bigger number arrived on 3 July. IPART's draft report on Electronic Lodgment Network Operator service fees proposes a one-off reduction in PEXA's regulated revenue requirement of approximately 20%, implemented through cuts of between 14.6% and 36.6% to key transfer products from FY28, with CPI increases thereafter and a next review in FY31 (PEXA 2026e). PEXA sizes the revenue effect at about A$70 million in FY28. The cuts fall on fees charged to legal practitioners; bank-facing fees are unchanged. IPART's own review page confirms the timeline: draft report 3 July, public hearing 21 July, final report to the Minister 30 September (IPART 2026).

The fight is over how you value the asset. IPART used a building block methodology, the tool Australian regulators apply to capex-heavy poles-and-wires monopolies, and derived an initial asset base of A$368 million for the PEXA Exchange. PEXA's submission proposes A$1.4 billion. The gap comes mostly from the assumed cost of capital across PEXA's start-up years: IPART applied an average WACC of about 20% between 2011 and 2019, while PEXA argues the actual internal rate of return achieved by its early investors over that period averaged 36% (PEXA 2026e). PEXA's sharpest framing: state governments and other investors sold the business in 2019 for A$1.6 billion, yet IPART's method implies those assets were worth about A$600 million at the time, in effect transferring about A$1.0 billion of value from today's shareholders to the original ones, including the selling governments (PEXA 2026e).

PEXA's counterattack is unusually public for an ASX company. Its August submission runs past 150 pages and is backed by four commissioned expert reports, including RBB Economics on market definition and Professor Stephen Gray on the cost of capital (PEXA 2026f; RBB Economics 2026; Gray 2026). It has also noted that its main competitor's own submission to the review sought a 5% price reduction, making a 20% draft outcome look extreme by the industry's own submissions (PEXA 2026e).

Two structural cushions matter for anyone sizing the risk. First, IPART only recommends. The final report goes to the NSW Government, which refers it to ARNECC, the national council of registrars, and ARNECC decides whether and how to implement. PEXA told the market on 18 August that ARNECC's process may take several months, and its results deck points to a determination around 2Q27-3Q27 (PEXA 2026d, 2026g). Second, ARNECC has recent form for moderation: in March 2026 it abandoned the interoperability program, the multi-year attempt to force PEXA's platform open to competitors, after independent reviews found the benefits did not justify the cost (PEXA 2026b). The same council that declined to break PEXA's network must now decide whether to cut its prices.

The toll booth is real, and this year it got stronger

Strip out the regulatory noise and the FY26 segment numbers describe a business with the economics of regulated infrastructure. The Australian Exchange processed 4.2 million transactions: 2.673 million transfers, up 5.4%; 964,000 refinances, up 9%; and 551,000 other lodgements (PEXA 2026d, 2026g). Australian revenue rose 8% to A$345.6 million on a 6.4% rise in market transaction volumes and a CPI-linked 2.2% rise in average revenue per transaction to A$80.60. Segment EBITDA rose 12% to A$192.8 million, a 55.8% margin, and it got there with operating expenses broadly flat at A$107.7 million (PEXA 2026a). That flat-cost-with-volume-growth pattern is what a toll booth looks like in the accounts.

FY (June year-end) Revenue (A$m) NPAT (A$m, statutory)
2022 279.8 21.9
2023 281.7 -21.8
2024 340.1 -18.0
2025 393.6 -76.1
2026 (continuing ops) 406.9 -15.9 total; +19.2 continuing

All rows from the lodged Appendix 4E filings (PEXA 2023, 2024, 2025, 2026b). The FY26 total statutory loss includes a A$35.1 million loss from discontinued operations, mainly impairments on the exit of the Digital Solutions businesses; the FY25 loss carried heavy impairments too. The five-year shape is a profitable young monopoly (FY22), three years of acquisition-diluted losses as the UK businesses were bought and rebuilt (FY23-FY25), and a return to continuing-operations profit in FY26.

The moat evidence sits in three places. Market coverage held at 90% of Australian property transfer settlements, with 28 million settlements processed since 2013 and more than A$1 trillion of annual property transactions running across the platform (PEXA 2026a, 2026b). ARNECC's March 2026 decision to end the interoperability program removed the only regulatory path to forced competition. And the CPI-linked price escalator delivered, as designed, through a soft volume year. The moat's weakness is now explicit: the same regulators who protect the network want to set its price, and the FY28 price is the open question.

Where the cash goes: A$158 million in, A$58 million out

The cash flow statement is the cleanest view of what shareholders own. Continuing operations generated A$148.2 million of operating cash flow in FY26; development spend of A$50.6 million and A$1.0 million of plant purchases took investing outflows to A$49.1 million; lease principal took another A$3.2 million. That reconciles to the company's A$93.5 million free cash flow definition (PEXA 2026a, 2026b, computed).

But the group is two businesses bolted together. The Australian segment produced A$192.8 million of EBITDA against A$35.1 million of Australian capex, call it A$158 million of pre-tax segment cash before group financing costs (computed from PEXA 2026a). International consumed A$57.6 million of operating cash while its EBITDA loss widened slightly to A$41.1 million on revenue of A$61.3 million (PEXA 2026a, 2026g). Every dollar of UK investment is currently funded by the Australian toll booth. That cross-subsidy is the investment case in one sentence, and it is why the IPART price cut and the UK adoption curve cannot be analysed separately: a 20% cut to Australian regulated revenue attacks the funding source of the entire international strategy.

Two accounting layers sit between that cash and reported profit. Amortisation of intangibles was A$93.6 million in FY26, little changed from A$94.5 million, mostly the trailing cost of the Optima Legal and Smoove acquisitions and capitalised platform development; that is the entire gap between the A$65.3 million NPATA and the A$19.2 million statutory profit (PEXA 2026a, 2026b). And the effective tax rate on core operations was 51% (A$27.3 million tax on A$53.6 million pre-tax), reflecting profits in Australia unrelieved by UK losses (PEXA 2026b, computed).

Return metrics deserve honesty rather than optimism. On carried capital, the Australia CGU is tested at A$1,257.8 million including A$693.6 million of goodwill; adding the International CGU's A$147.5 million gives roughly A$1.4 billion of invested capital. Statutory continuing EBIT of A$54.1 million taxed at 30% gives a computed ROIC near 2.7%, a number dragged down by acquisition intangibles rather than by the operating business. The cleaner unit economics: the Australian segment's pre-tax cash yield on its own carried capital is about 12.5%, and the FY25-to-FY26 continuing-operations comparison shows incremental EBITDA margin of roughly 61% on A$27.4 million of added revenue (all computed from PEXA 2026a, 2026b). I have not forced a single incremental ROIC figure: the FY25 restatement for Digital Solutions and the acquisition-heavy capital history would make one ratio misleading.

The balance sheet, at least, is no longer a concern. Facilities were cut to A$330 million and extended to July 2029-July 2031, drawn to A$225 million, with interest cover at 9.6x and no covenant breaches (PEXA 2026b). The buy-back stays paused; the last tranche, 1.66 million shares at an average A$11.35, was completed in April 2025 at a price 55% above today's (PEXA 2025).

Management's own downside arithmetic

The audited accounts give the most useful scenario skeleton available, because PEXA's directors had to commit numbers to the IPART range. For impairment testing, management adopted a probability-weighted FY28 regulated price reduction of 13.2%, sitting between IPART's minus 20% and PEXA's CPI-only position, and recorded no impairment (PEXA 2026b). The sensitivity is disclosed: if IPART's draft is adopted in full, the Australia CGU's recoverable amount falls to A$1,215.5 million against a A$1,257.8 million carrying value, forcing an impairment charge of up to A$42.3 million (PEXA 2026b).

The International CGU carries A$147.5 million against a recoverable amount of A$251.7 million, 71% headroom, tested at a 13.9% discount rate over seven years. The disclosed break-even: delay the PEXA platform cash flows by two years, modelled as a nine-year path to stable cash generation, and a A$9.3 million impairment appears (PEXA 2026b). That two-year delay is precisely the risk if the Australian price cut crimps the money available to chase UK adoption.

The FY26 result also completes the portfolio cleanup. The strategic review of Digital Solutions finished with the businesses held for sale and the exit broadly complete, the final sale expected by the end of calendar 2026 (PEXA 2026b). What remains is the exchange, the UK platform, the new PEXA Clear compliance product launched into the 1 July 2026 anti-money-laundering regime, and a capital-light New Zealand pilot starting October 2026 (PEXA 2026a, 2026g).

What A$7.31 is pricing

At A$7.31, with 175.8 million shares on issue (PEXA 2026b) and A$158.7 million net debt, the enterprise value is about A$1,444 million (computed). That is 9.5x FY26 EBITDA, and 10.4-11.9x the FY27 guided EBITDA range of roughly A$121-139 million (revenue guide times margin guide, computed). For a business whose Australian engine earns a 55.8% margin with 90% market coverage, those are regulated-utility-adjacent multiples with a startup attached, which is arguably the point: the market now values PEXA as a price-regulated asset whose regulator has proposed a deep cut.

The scenarios below are my computations, built from the disclosed sensitivity grid, the IPART dollar figures, and segment economics, then compared with the price. The single most important input is the FY28 Australian regulated price outcome; the second is the volume cycle.

Scenario FY28 Australia price outcome Volumes (AU transfers) Group FY28 EBITDA (computed) Multiple Value per share
Severe downside -20%, unphased -10% ~A$70-90m 7.5-8.0x A$3.80-4.60
Bear -20%, phased 4 years -10% ~A$115-125m 8.5-9.5x A$6.20-7.40
Base -13.2% (management's weighted case) -5%, stabilising ~A$125-135m 10-10.5x A$7.80-9.20
Bull CPI-only (ARNECC declines the cut) +3% ~A$165-180m 11-12x A$11.00-13.00

Mechanics, so the ranges can be checked: a A$70 million regulated revenue cut flows through to Australia segment EBITDA at roughly 85%, say A$59.5 million, because transfer fees carry almost no incremental cost; the volume deltas apply about 90% flow-through to transfer revenue of A$264.6 million; International EBITDA is assumed between -A$25 million and -A$35 million by FY28 depending on the scenario; net debt of A$158.7 million is deducted and 175.8 million shares divide the result (all computed from PEXA 2026a, 2026b, 2026e).

A two-variable sensitivity on FY28 group EBITDA (A$m, computed) shows where the value actually moves:

FY28 group EBITDA Volumes +3% Volumes -5% Volumes -10% Volumes -15%
CPI-only pricing ~172 ~153 ~141 ~129
-20% phased (year one) ~157 ~138 ~126 ~114
-13.2% weighted ~133 ~114 ~102 ~90
-20% unphased ~112 ~93 ~82 ~70

Read the table backwards from the price. The market's A$1,444 million enterprise value needs about A$144 million of FY28 EBITDA at a 10x multiple to stand still. That sits between the phased-cut-with-weak-volumes cell (~138) and the CPI-only-with-minus-10%-volumes cell (~141). In plain terms, A$7.31 already prices a meaningful regulatory haircut. Friday's close of A$6.68 was pricing toward the unphased end; Monday's bounce moved the pricing back to a hard-but-transactional outcome. This is the same conclusion management's own probability weighting implies, which is either comfort or correlation.

The peer frame is instructive rather than decisive: ASX Limited, the other near-monopoly exchange platform on this market, spends its capital debates on technology replacement rather than fee cuts, and trades on materially higher margins of safety from its regulator. PEXA's discount to that frame is the regulatory discount, and it compresses or widens with the September letter (ASX Limited 2026, cited for context).

The September letter, and what follows it

The reaction verdict, on the evidence: Friday's 17.4% fall was an over-reaction to a guidance reset that the 18 August update had largely pre-signalled, and Monday's 9.4% recovery was a correction of that overshoot rather than a verdict on the business. The net two-session fall of 9.6% from Thursday's close is a defensible price for halved near-term earnings. What neither session resolved is the A$70 million question, because the FY27 guidance and the IPART outcome are different risks of different sizes: the guidance cuts FY27 NPAT by about A$14 million at midpoint, while the unphased fee cut removes roughly A$50-60 million of annual EBITDA from FY28 (computed). The market has spent its attention on the smaller number.

The calendar from here is unusually legible. IPART's final report goes to the NSW Government by 30 September 2026, a date confirmed on the tribunal's own review page (IPART 2026). The Government refers it to ARNECC, whose consultation and determination PEXA expects to stretch across 2027, pointing to 2Q27-3Q27 (PEXA 2026d, 2026g). Implementation of any cut would begin with FY28 pricing. In parallel: monthly Australian transfer volumes will show within weeks whether July's ~192,000 is a trough or a waypoint; the NZ pilot starts in October; NatWest Sale and Purchase delivery is targeted for late 3Q27; and the FY27 half-year lands in February 2027.

What to watch

Four thresholds carry most of the information between now and the FY27 results. First, the final report's structure: a 20% cut with no phase-in moves the severe scenario to the front of the queue, while any softening or phase-in confirms the base case; the A$42.3 million impairment sensitivity in the accounts marks the accounting consequence. Second, Australian monthly transfer volumes: the FY27 margin guide already embeds a 12-15% decline, so prints sustained below ~190,000 say the guidance itself is optimistic, while anything above ~210,000 says it is conservative. Third, International operating cash outflow against the -A$55 to -65 million guide, because the UK strategy's funding depends on the Australian engine. Fourth, NatWest Sale and Purchase milestones, where slippage past 3Q27 pressures the International CGU's disclosed headroom.

Confidence, missing information and source notes

This article rests on the lodged FY26 results announcement, the full FY26 annual report and Appendix 4E, the half-year report, the 3Q26 and 18 August updates, the FY23-FY25 Appendix 4E filings, PEXA's July commentary and August submission to IPART with two of the four expert reports, the results presentation, and the IPART review page, all retrieved and read this run. Three gaps are worth naming. IPART's draft report itself is characterised here through PEXA's commentary and the tribunal's review page, not the tribunal's full text, so the regulator's internal reasoning is second-hand. Broker positioning, including the July downgrade and Macquarie's unchanged positive stance on the stock, is cited from headlines only. And the FY27 guidance's treatment of significant items is not fully specified in the release. Price reconciliation note: one aggregator showed a Monday close of A$7.42; the A$7.31 close used here is confirmed by two independent sources and the session wrap (Google Finance 2026; Fool 2026; StockAnalysis 2026). All scenario values, flow-through rates, ROIC, yields and per-share ranges above are author computations from the cited filings and are labelled as such.

References

  • PEXA 2026a, PEXA Reports Full Year 2026 Results, ASX announcement, 28 August 2026
  • PEXA 2026b, PEXA Group Limited Annual Report 2026 with Appendix 4E
  • PEXA 2026c, PEXA 3Q26 update, ASX announcement, 4 May 2026
  • PEXA 2026d, PEXA Responds to IPART's Draft Report on ELNO Service Fees, ASX announcement, 18 August 2026
  • PEXA 2026e, Investor presentation commentary on IPART draft report, 3 July 2026
  • PEXA 2026f, PEXA's response to IPART's Draft Report on ELNO Service Fees, August 2026
  • PEXA 2026g, FY26 Results Investor Presentation, 28 August 2026
  • PEXA 2026h, Appendix 4D and Half Year Financial Report, 27 February 2026
  • PEXA 2025, Appendix 4E and FY25 Annual Report
  • PEXA 2024, Appendix 4E, year ended 30 June 2024
  • PEXA 2023, Appendix 4E, year ended 30 June 2023
  • RBB Economics 2026, Expert report re IPART review, August 2026
  • Gray 2026, Prof Stephen Gray, Expert report re IPART review, August 2026
  • IPART 2026, Review of Electronic Lodgment Network Operator service fees, review page and timeline
  • RBA 2026, Cash rate target, decisions to 12 August 2026
  • Google Finance 2026, PXA:ASX quote, 31 August 2026
  • ASX 2026, ASX company page for PEXA Group Limited (PXA)
  • StockAnalysis 2026, PXA daily price history, 24-31 August 2026
  • ASX Limited 2026, peer context (not retrieved this run)
  • Motley Fool 2026, Pexa jumps to FY26 profit, 31 August 2026
  • Fool 2026, Top 10 ASX 200 shares today, 31 August 2026